Insider Transactions in Q4 2022 at Jazz Pharmaceuticals PLC (JAZZ)
Insider Transaction List (Q4 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 21
2022
|
Renee D Gala President & COO |
SELL
Open market or private sale
|
Direct |
2,635
-7.49%
|
$421,600
$160.0 P/Share
|
|
Dec 13
2022
|
Samantha Pearce EVP, Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
531
-4.48%
|
$82,305
$155.45 P/Share
|
|
Dec 13
2022
|
Samantha Pearce EVP, Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
531
+4.29%
|
$57,879
$109.45 P/Share
|
|
Dec 09
2022
|
Robert Iannone EVP, Global Head of R&D |
SELL
Open market or private sale
|
Direct |
1,844
-4.83%
|
$278,444
$151.54 P/Share
|
|
Dec 05
2022
|
Patricia Carr SVP, Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
63
-1.05%
|
$9,576
$152.06 P/Share
|
|
Dec 05
2022
|
Daniel N Swisher Jr President and COO |
SELL
Other acquisition or disposition
|
Direct |
10,465
-18.22%
|
-
|
|
Dec 02
2022
|
Jennifer E. Cook Director |
SELL
Open market or private sale
|
Direct |
420
-7.13%
|
$64,680
$154.68 P/Share
|
|
Dec 02
2022
|
Mark Douglas Smith Director |
SELL
Open market or private sale
|
Direct |
420
-7.13%
|
$64,680
$154.68 P/Share
|
|
Dec 01
2022
|
Bruce C Cozadd Chairman & CEO |
SELL
Open market or private sale
|
Direct |
1,000
-0.27%
|
$157,000
$157.0 P/Share
|
|
Nov 22
2022
|
Patrick G Enright Director |
SELL
Open market or private sale
|
Indirect |
2,000
-100.0%
|
$304,000
$152.88 P/Share
|
|
Nov 22
2022
|
Patrick G Enright Director |
SELL
Open market or private sale
|
Direct |
4,974
-10.91%
|
$741,126
$149.54 P/Share
|
|
Nov 16
2022
|
Neena M Patil EVP & Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
3,510
-11.59%
|
$498,420
$142.34 P/Share
|
|
Nov 14
2022
|
Finbar Larkin SVP, Technical Operations |
SELL
Open market or private sale
|
Direct |
197
-1.0%
|
$29,353
$149.33 P/Share
|
|
Nov 10
2022
|
Samantha Pearce EVP, Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
1,063
-4.49%
|
$164,765
$155.0 P/Share
|
|
Nov 10
2022
|
Samantha Pearce EVP, Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,063
+4.3%
|
$115,867
$109.45 P/Share
|
|
Nov 10
2022
|
Bruce C Cozadd Chairman & CEO |
SELL
Open market or private sale
|
Direct |
2,000
-0.53%
|
$300,000
$150.0 P/Share
|
|
Oct 03
2022
|
Bruce C Cozadd Chairman & CEO |
SELL
Open market or private sale
|
Direct |
45,185
-3.72%
|
$6,099,975
$135.0 P/Share
|
|
Oct 03
2022
|
Bruce C Cozadd Chairman & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
62,905
+13.05%
|
$3,711,395
$59.13 P/Share
|